+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit



Riding the rollercoaster: the ups and downs in out-of-pocket spending under the standard Medicare drug benefit



Health Affairs 24(4): 1022-1031



This study projects how much Medicare beneficiaries who sign up for the standard Part D drug benefit in 2006 will pay in quarterly out-of-pocket payments through 2008. In the first year we estimate that about 38 percent of enrollees will hit the benefit's no-coverage zone, known as the "doughnut hole," and that 14 percent will exceed the catastrophic threshold. Because drug spending is highly persistent over time, beneficiaries who experience the biggest gaps in coverage are likely to do so year after year, with potentially serious financial consequences.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050220426

Download citation: RISBibTeXText

PMID: 16012142

DOI: 10.1377/hlthaff.24.4.1022


Related references

How the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences 65(4): 502-507, 2010

Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act. Medical Care 55(1): 43-49, 2016

Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?. Research in Social & Administrative Pharmacy 6(2): 90-99, 2010

National trends in out-of-pocket prescription drug spending among elderly medicare beneficiaries. Expert Review of Pharmacoeconomics & Outcomes Research 5(3): 297-315, 2005

Association of Prescription Drug Price Rebates in Medicare Part D With Patient Out-of-Pocket and Federal Spending. JAMA Internal Medicine 177(8): 1185-1188, 2017

Hospitals' fears are realized. Spending bill would use Medicare surplus for drug benefit, reform effort. Modern Healthcare 31(13): 9-9, 2001

Effect of cost sharing on prescription drug use by Medicare beneficiaries prior to the Medicare Drug Benefit and potential adverse selection in the benefit. Journal of the American Pharmacists Association 49(1): 18-25, 2009

Impacts of generic competition and benefit management practices on spending for prescription drugs: evidence from Medicare's Part D benefit. Medicare & Medicaid Research Review 4(1): -, 2016

The impact of the medicare part D prescription drug benefit on prescription utilization and out-of-pocket expenditures. Journal of Investigative Medicine 56(3): 620, 2008

Medicare program; Medicare Advantage and prescription drug benefit programs: negotiated pricing and remaining revisions; prescription drug benefit program: payments to sponsors of retiree prescription drug plans. Final rule. Federal Register 77(8): 1877-1883, 2012

Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program. Final rule. Federal Register 83(73): 16440-16757, 2018

Medication strategies used by Medicare beneficiaries who reach the Part D standard drug-benefit threshold. American Journal of Health-System Pharmacy 65(11): 1062-1070, 2008

Helping Medicare patients benefit from the new Medicare drug benefit: an overview with practice tips. American Journal of Geriatric Cardiology 14(6): 291-297, 2005

Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer. JAMA Oncology (): -, 2016

Out-of-hand spending. Medicare+Choice out-of-pocket costs on the rise. Modern Healthcare 33(33): 7, 14-7, 14, 2003